Aim: Our previous study demonstrated that the cystatin C-based chronic kidney disease (CKD)-EPI equation and combined by serum creatinine (CKD-EPIscr-cys) had better capability to accurately evaluate glomerular filtration rate in the CKD participants. Considering that the accuracy of estimated glomerular filtration rate (eGFR) remains less ideally, it is essential to modify the equation by including the Chinese eGFR racial factor in order to improve its performance. Methods: Two prospective cohorts were enrolled in 2 medical centers. New equations were developed in 529 participants and validated in 313 participants. Reference glomerular filtration rate (rGFR) was taken by 99m Tc-DTPA renal dynamic imaging method (Gates method). The primary outcomes of this study were bias, precision (interquartile range of difference [IQR]), and accuracy (the proportion of eGFR within 30% of rGFR [P30] and root mean square error [RMSE]) of eGFR versus rGFR. Results: In a development data set, Chinese coefficients for CKD-EPIscr (C-CKD-EPIscr), CKD-EPIcys (C-CKD-EPIcys), and CKD-EPIscr-cys (C-CKD-EPIscr-cys) were 0.871, 0.879, and 0.891, respectively. In a validation data set, C-CKDEPIcys was the most accurate with highest P30 value (62.3%), relative lowest IQR (15.45), and RMSE (0.80) among 6 equations, though the bias of C-CKD-EPIcys was not better than CKD- EPIcys. C-CKD-EPIscr and C-CKD-EPIscr-cys equations were improved in bias (p < 0.001), precision, and accuracy (p = 0.004 and < 0.001 for P30) compared with CKD-EPIscr and CKDEPIscr-cys. Conclusion: C-CKD-EPIcys was the most accurate with the highest P30 value, relative lowest IQR, and RMSE among 6 equations. C-CKD-EPIscr and C-CKD-EPIscr-cys equations were improved in bias, precision, and accuracy. Other external validation of these equations is needed.
Introduction
Chronic kidney disease (CKD) is a global public health problem [1] . The prevalence of CKD in adults in China was 10.8% [2] . Awareness of CKD is only 10.04% from a national crosssectional survey in China [3] . CKD is characterized by decreased estimated glomerular filtration rate (eGFR) and/or increased albuminuria, present for > 3 months, and is associated with adverse outcomes (all-cause mortality, acute kidney injury, and end-stage renal disease), independent of hypertension and diabetes [4] , age [5] , or sex [6] . CKD may carry a coronary heart disease risk similar to that of diabetes. The estimated lifetime risk of CKD stage 3a was > 50% [7] , higher than those for diabetes (33-39%), coronary heart disease (32-49%), and invasive cancer (38-45%) [8] .
eGFR is a primary means of screening for CKD in epidemiological investigations. Our previous study [9] demonstrated that the CKD-EPI equation combined by serum creatinine and cystatin C (CKD-EPIscr-cys) [10] had better capability to accurately evaluate GFR in Chinese ethnic participants with CKD stages 1-2. The application of the cystatin C-based equations may be the optimal one for patients of moderately to severely injured GFR. Considering that the accuracy in the entire range of participants of our study remains less ideally, we suggest that the addition of the Chinese racial factor may improve eGFR performance [9] . In this study, we aimed to add the Chinese racial factor for the improvement of eGFR performance. We compared their bias, precision, and accuracy with the 2012 CKD-EPI equations [10] .
Materials and Methods

Study Design
A total of 842 Chinese CKD patients were included from 2 general hospitals between August 1, 2009 , and December 31, 2017, in 2 megalopolises of China. The criteria of inclusion and exclusion were seen in our previous work [9] . The study was approved by the Institutional Review Boards of Nanjing First Hospital affiliated to Nanjing Medical University (IRB No. 86-025-52271039-21). The ClinicalTrials.gov number was NCT02841371.
Primary Outcomes
The primary outcomes of this study were bias, precision, and accuracy of eGFR versus reference glomerular filtration rate (rGFR). Bias was defined as the median results of differences between eGFR and rGFR. Precision was defined as the interquartile range (IQR) of the differences between eGFR and rGFR. Accuracy was calculated as the proportion of eGFR within 30% of rGFR and root mean square error (RMSE) of mean difference between eGFR and rGFR.
Measurements of Creatinine, Cystatin C, and GFR
Enzymatic method was used to measure serum creatinine (Scr) concentration, traceable to National Institute of Standards and Technology creatinine standard reference material (SRM 967). Automated particle-enhanced immunonephelometry assay was applied to examine serum cystatin C, which was calibrated against the international certified reference material ERM-DA471. All fasting serum samples were assayed on an Olympus AU5400 autoanalyser (Olympus Corporation, Mishima, Japan), in conformity with manufacturer's instructions.
A 99m Tc-DTPA renal dynamic imaging measurement by modified Gates method was taken as the rGFR, calibrated with dual plasma sample 99m Tc-DTPA GFR, which had been described in previous reports [9, 11, 12] .
Development and Validation of Equations
The new Chinese coefficient to modify the 2009 and 2012 CKD-EPI equations for Chinese was calculated from the development data set of 529 participants from Shanghai Fifth People's Hospital affiliated to Fudan University. The revised equations were derived in the development data set by using a linear regression model. The revised CKD-EPI equations for Chinese were validated in the validation data set of 313 participants from Nanjing First Hospital affiliated to Nanjing Medical University.
Statistical Analysis
In 2002, the Kidney Disease Outcomes Quality Initiative guidelines pointed out that at least 100 samples were needed to test the new GFR equation. According to our previous studies [11] , with a deviation of 5 for the paired difference (our registered information, ClinicalTrials.gov registration number: NCT02841371), the deviation of the standard deviation 20, power 0.8, alpha = 0.05, 2-sided test, using Wilcoxon paired rank test, with PASS11 software system, the sample size is required in 128 cases. A total of 313 participants were included in the validation data set of this study, so the sample size has met the statistical requirements.
The data sets were not normally distributed (p < 0.001, Kolmogorov-Smirnov test); so, nonparametric statistics (Wilcoxon matched-pairs signed-rank test) were carried out. Bias, precision, and accuracy were applied to assess the performance of each equation. Bias was Scr, serum creatinine; Scys, serum cystatin C; rGFR, reference glomerular filtration rate (using the 99m Tc-DTPA renal dynamic imaging method); eGFR, estimated glomerular filtration rate.
calculated as the median results of differences between eGFR and rGFR. Precision was defined as the IQR of the differences between eGFR and rGFR. Accuracy was defined as the proportion of eGFR within 30% of rGFR (P30) and RMSE of mean difference between eGFR and rGFR.
McNemar test was used to compare the P30 of the C-CKD-EPIscr against the P30 of CKDEPIscr equation and the C-CKD-EPIscr-cys against the P30 of CKD-EPIscr-cys equation. Classical Bland-Altman plot analysis was performed to compare rGFR with eGFR. Curve fitting was implemented by comparison between eGFR and rGFR for each patient graphically by plotting eGFR and the difference (eGFR -rGFR) against rGFR. Data were considered statistically significant at p < 0.05. SPSS software version 18.0 (SPSS, Chicago, IL, USA) was used to perform all statistical analyses. Scr was shown as mg/dL; Scys was shown as mg/L; age was shown as years. Scr, serum creatinine; Scys, serum cystatin C; CKD-EPIscr, serum creatinine-based CKD-EPI equation which was developed in 2009; CKD-EPIcys, cystatin C-based CKD-EPI equation which was newly developed in 2012; CKD-EPIscr-cys, serum creatinine and cystatin C-based CKD-EPI equation which was newly developed in 2012; C-CKD-EPIscr, CKD-EPIscr equation modified for China; C-CKD-EPIcys, CKD-EPIcys equation modified for China; C-CKDEPIscr-cys, CKD-EPIscr-cys equation modified for China. 
Results
Characteristics of the Study Population
A total of 842 participants (476 male and 366 female) with CKD were enrolled in this study. Median age, rGFR, Scr, and cystatin C were 65, 47 mL/min/1.73 m 2 , 114 μmol/L, and 1.45 mg/L, respectively. The detailed demographic and clinical characteristics of participants were shown in Table 1 .
eGFR Equations All equations were listed in Table 2 . The coefficients to modify CKD-EPIscr, CKD-EPIcys, and CKD-EPIscr-cys for a Chinese population were 0.871 (0.848-0.891 for 95% CI), 0.879 (0.857-0.897), and 0.891 (0.870-0.909), respectively. The coefficient to modify CKD-EPIcys for Chinese female was 0.999 (0.997-1.000), almost equal to 1.0. For this reason, we omitted the female coefficient of C-CKD-EPIcys. The coefficient to modify CKD-EPIscr-cys for Chinese female was 0.959 (0.936-0.981).
Comparison of Performance of the Equations
Performance of the equations in the validation data set was summarized in Table 3 , and bias plots of the 6 equations against rGFR were shown in Figure 1 . CKD-EPIscr, CKD-EPIscrcys, and C-CKD-EPIscr equations tended to overestimate GFR in the CKD patients, and CKDEPIcys and C-CKD-EPIcys equations tended to underestimate GFR. C-CKD-EPIcys appeared to be the most accurate with highest P30 value (62.3%), relative lowest IQR (15.45), and RMSE (0.80) among 6 equations, though the bias of C-CKD-EPIcys was not better than CKD-EPIcys. C-CKD-EPIscr and C-CKD-EPIscr-cys equations were improved in bias (p < 0.001), precision, and accuracy (P30 and RMSE; p = 0.004 and < 0.001 for P30). Bland-Altman analysis demonstrated a consistent result (Fig. 1) . 
Discussion
In this study, we added the Chinese racial factor for the improvement of eGFR performance of the 2009 CKD-EPI equation and two 2012 CKD-EPI equations. The new Chinese coefficient to modify the 2012 CKD-EPI equations for Chinese was calculated from the development data set of 529 participants. The revised CKD-EPI equations for Chinese were validated in the validation data set of 313 participants. We compared their bias, precision, and accuracy with the CKD-EPI equations. The coefficients to modify CKD-EPIscr, CKD-EPIcys, and CKD-EPIscr-cys for the Chinese population were 0.871, 0.879, and 0.891, respectively. The coefficient to modify CKD-EPIcys for Chinese female was 0.999, almost the same as 1.0, so we omitted the female coefficient. It is suggested that women's coefficient be unnecessary for cystatin C-based GFR estimation. Other studies also showed that cystatin C was independent of sex [13] [14] [15] .
We observed that C-CKD-EPIcys was the most accurate with the highest P30 value (62.3%), relative lowest IQR (15.45), and RMSE (0.80) among 6 equations. C-CKD-EPIscr equation was improved in bias (p < 0.001), precision, and accuracy (p = 0.004 for P30). C-CKDEPIscr-cys equation was also improved in bias (p < 0.001), precision, and accuracy (p < 0.001 for P30). There has been a distinct improvement in the 3 modified equations according to the fit of the data.
There is some literature on cystatin C stating that it is nearly independent of age, sex, and race. Many cystatin C equations that have been proposed in the past only had one variable (cystatin C) in the equation [13] [14] [15] . The CAPA equation stands for "Caucasian Asian Paediatric and Adult" cohort and only contains cystatin C and age in the equation [14] . Recently, the new FAS equation (full age spectrum) [16] has shown to be applicable to cystatin C using a fixed normalization factor for cystatin C (0.82 mg/L for subjects up to 70 years and 0.95 mg/L beyond that age), independent of sex and probably of race. Further study on the FAS equation for serum creatinine and serum cystatin C implied that the CKD-EPIcysC equation shows serious bias compared to measured GFR [15] . However, evaluation of the CAPA and FAS equations in a diverse population [17] indicates that these newer GFR estimating equations are not more accurate than the CKD-EPI equations in adults. Levey et al. [17] concluded that "current evidence does not support routinely reporting eGFR in adults using these newer equations rather than the CKD-EPI equations." A study recently showed that [18] the performance of the FASscr-cys equation is better than that of the CKD-EPIscr-cys equation in the Chinese population. Whether FASscr-cys equation is better than our modified CKD-EPIscrcys equation or CKD-EPIcys equation needs further research.
Cystatin C is a 13-KD protein that is freely filtered by glomerulus, reabsorbed and catabolized by the renal tubule. It is produced at a constant rate by all nucleated cells and distributed throughout the extracellular fluid. Compared to creatinine, serum cystatin C is less influenced by muscle mass or diet. Some errors due to the non-GFR determinants of creatinine and cystatin C are smaller in an equation that uses both markers than in an equation that uses only one marker. The KDIGO guideline suggests that cystatin C should be measured in adults with an eGFRscr of 45-59 mL/min/1.73 m 2 who do not have albuminuria [19] . The use of cystatin C strengthens the association between the eGFR and the risks of death [20] . CKD-EPIcys equation performed well in Japan, which suggested that cystatin C-based equations can be used in patients with different races in whom race modification is not needed [21] . The Japanese coefficient for CKD-EPIscr-cys was 0.908 and showed good performance in Japanese. The coefficient to modify CKD-EPIscr-cys for our Chinese population was 0.891, which was similar to Japanese coefficient for CKD-EPIscr-cys. Our study indicated that C-CKD-EPIscr-cys equation was improved in bias, precision, and accuracy.
Chronic illnesses such as diabetes mellitus, dyslipidemia, and CKD are relatively silent and rely on the clinical laboratory for diagnosis, particularly in their early stages. Probably, there is no other disease similar to CKD in which patients experience greater loss of organ function before symptoms start to appear [22] , so evaluation of GFR for CKD is of paramount importance. The KDIGO guideline suggests using the 2012 CKD-EPI cystatin C and 2012 CKD-EPI creatinine-cystatin C equations, respectively, or alternative cystatin C-based GFR estimating equations if they have been shown to improve accuracy of GFR estimates compared to the 2012 CKD-EPI cystatin C and 2012 CKD-EPI creatinine-cystatin C equations [19] .
C-CKD-EPIcys and C-CKD-EPIscr-cys equations outperformed 2012 CKD-EPI equations for Chinese in our study. It all starts with screening and detection of a silent disease, which give years of opportunity for discovery and modification of its natural history [22] .
The CKD-EPI investigators assessed accuracy as P30, which takes into account greater errors at higher values and the absolute values of the difference between measured and eGFR [23] . For this reason, most GFR equation studies take P30 for accuracy. Although other parameters (such as P10 and P20, representing the percentages of estimations falling within ±10 and ±20% of measured GFR, respectively) have also been used, P30 deserves special consideration. It is worth noting that P30 was defined in the absence of any clinical or statistical rationale for considering it an acceptable margin of error [24] .
There are also some limitations of this study. First, we use dynamic renal imaging as the rGFR method and may result in great bias. The Nephrology Conference held in 1996 in the USA recommended the adoption of the 2-plasma method [25] . However, the GFR obtained by the modified formula for the calculation of GFR used in this article was derived from studies, calibrated with dual plasma sample 99m Tc-DTPA GFR, and reflected kidney function more accurately, and was closer to the true value than those that did not calibrated with dual plasma method [12] . DTPA renal dynamic imaging method was more practical and widely used in routine clinic than dual plasma method [26] . Second, we validated the above 6 equations from 313 participants. The number of validation participants is small. Third, all study participants had CKD. The equations are based on data from Chinese CKD patients; thus, it is not clear whether it is applicable to healthy population. Fourth, extrarenal elimination of serum cystatin C was not measured.
In summary, our study demonstrated that C-CKD-EPIcys was the most accurate with the highest P30 value, relative lowest IQR, and RMSE among 6 equations. C-CKD-EPIscr and C-CKD-EPIscr-cys equations were improved in bias, precision, and accuracy compared with CKD-EPIscr and CKD-EPIscr-cys. Other external validation of these equations is needed.
